The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Pharmacodynamics of antimicrobial drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.650 · Cited by 641
Pharmacodynamics of Levofloxacin: A New Paradigm for Early Clinical Trials
Preston, S. L. (1998) · JAMA · doi:10.1001/jama.279.2.125 · Cited by 589
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Rybak, M. J., Abate, B. J., Kang, S. L., Ruffing, M. J., Lerner, S. A., & Drusano, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1549 · Cited by 431
Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00007 · Cited by 306
Lamer, C., de Beco, V, Soler, P., Calvat, S., Fagon, J. Y., Dombret, M. C., Farinotti, R., Chastre, J., & Gibert, C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.281 · Cited by 297
In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid)
Andes, D., van Ogtrop, M. L., Peng, J., & Craig, W. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3484-3489.2002 · Cited by 278
LEPPER, M. H. (1951) · A.M.A. Archives of Internal Medicine · doi:10.1001/archinte.1951.03810100073006 · Cited by 254
Antibiotic Pharmacodynamics in Cerebrospinal Fluid
Lutsar, I., McCracken, Jr., & Friedland, I. R. (1998) · Clinical Infectious Diseases · doi:10.1086/515003 · Cited by 242
Brook, I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.361 · Cited by 241
The Pharmacodynamics of Aminoglycosides
Lacy, M. K., Nicolau, D. P., Nightingale, & Quintiliani, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514620 · Cited by 231
Pharmacodynamics of Fluoroquinolones
Lode, H., Borner, K., & Koeppe, P. (1998) · Clinical Infectious Diseases · doi:10.1086/514623 · Cited by 220
Stevens, D. L., Van, S., & Bryant, A. E. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1401 · Cited by 211
Bodey, G. P., Ketchel, S. J., & Rodriguez, V. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90242-0 · Cited by 206
Pharmacodynamics and dosing of aminoglycosides
Turnidge, J. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00057-6 · Cited by 192
Chambers, H. F. “., & Kennedy, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.4.510 · Cited by 96
Clinical pharmacodynamics of quinolones
Ambrose, P. G., Bhavnani, S. M., & Owens, R. C. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00061-8 · Cited by 82
Jacqueline, C., Batard, É., Grandière-Pérez, L., Boutoille, D., Hamel, A., Caillon, J., Kerguéris, M.-F., Potel, G., & Bugnon, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3706-3711.2002 · Cited by 77
Ingerman, M. J., Pitsakis, P. G., Rosenberg, A. F., & Levison, M. E. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.4.707 · Cited by 57
Self-citationPharmacodynamics to combat resistance
Woodnutt, G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020890 · Cited by 43
Cited by
General Principles of Antimicrobial Therapy
Leekha, S., Terrell, C. L., & Edson, R. S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0639 · Cited by 878
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli
Cui, Y., Zhao, Y., Tian, Y., Zhang, W., Lü, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.057 · Cited by 862
Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
French, G. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl393 · Cited by 441
Antibacterial Efficiency of Graphene Nanosheets against Pathogenic Bacteria via Lipid Peroxidation
Krishnamoorthy, K., Veerapandian, M., Zhang, L.-H., Yun, K., & Kim, S. J. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp3047054 · Cited by 420
Mogana, R., Adhikari, A., Tzar, M. N., Ramliza, R., & Wiart, C. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2837-5 · Cited by 390
Metadata
- Authors
- Levison, M. E.
- Venue
- Infectious Disease Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 18
- Issue
- 3
- Pages
- 451-465
- ISSN
- 0891-5520 (ISSN-L)
- OpenAlex
- W2171378731
- Cited by
- 277
- References
- 23
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.